Stem Cells are Where Biotech Was 30 Years ago - An Interview with Robin Young

Bloomberg recently interviewed author and stem-cell "industry" specialist Robin Young for his views.  "Biotech needs stem cell research," he says, and the first stem cell-based treatments for auto-immune diseases, may be coming through the FDA cycle in about two years, he says.

Play Video

Stem Cell Industry Where Biotech was 30 years ago: An Interview with Robin Young - Bloomberg

Bloomberg - (BLOOM)

Mar. 23, 2007. 12:59 PM EST